Skip to main content

Oric Pharmaceuticals, Inc.

ORICNASDAQ
$12.21-0.32 (-2.52%)as of Oct 2, 2026
Legend
Insider buy
Insider sell
Congress buy
Congress sell
Hedge Funds
bought vs sold
Greener markers show more buyers; redder markers show more sellers.
Company share activityNet buybacksNo changeNet dilution
Marker size reflects transaction size.
  • Insider buy
  • Insider sell
  • Congress buy
  • Congress sell
  • Hedge Funds bought vs sold
Share activityNet buybacksNo changeNet dilution

Marker size reflects transaction size. Greener fund markers mean more buyers.

  • Insider Buy
  • Insider Sell
  • Congress Buy
  • Congress Sell
  • Hedge funds bought vs sold
  • BuybackNo changeNet dilution

Oric Pharmaceuticals, Inc. price and activity chart data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+7.8%). 0 insider or congressional trades plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding

Largest institutional holders

13F · Q2 2026
Fund% of company heldValue% of portfolioQuarterly activity
Nextech Invest Ltd.6.91%$77.6M3.68%Not reported
BlackRock, Inc.6.58%$73.9M0.00%Not reported
EcoR1 Capital, LLC6.49%$72.9M3.54%Not reported
Viking Global Investors LP4.95%$55.5M0.16%Reduce 11.98%
State Street Corp4.72%$53M0.00%Not reported
SR One Capital Management, LP4.45%$50M4.81%Add 2.22%
Venrock Adviser, LLC4.17%$46.8M1.42%Not reported
NEA Management Company, LLC3.97%$44.6M2.81%Not reported
Vanguard Capital Management LLC3.81%$42.8M0.00%Not reported
AIHC Capital Management Ltd3.69%$41.5M39.77%Add 55.66%
Alkeon Capital Management LLC3.61%$40.5M0.05%Reduce 16.98%
Column Group LLC3.42%$38.3M43.53%Not reported
Siren, L.L.C.2.89%$32.5M0.66%Not reported
FMR LLC2.54%$28.5M0.00%Not reported
Citadel Advisors LLC2.50%$28.1M0.00%Not reported
Goldman Sachs Group Inc2.37%$26.6M0.00%Not reported
Geode Capital Management, LLC2.02%$22.6M0.00%Not reported
First Turn Management, LLC1.95%$21.8M2.34%Not reported
Orbimed Advisors LLC1.94%$21.8M0.40%Not reported
Integral Health Asset Management, LLC1.83%$20.6M0.81%Add 35.71%
MPM Bioimpact LLC1.82%$20.4M1.24%Add 4.34%
Vivo Capital, LLC1.78%$20M1.83%Not reported
Dimensional Fund Advisors LP1.74%$19.5M0.00%Not reported
Morgan Stanley1.73%$19.4M0.00%Not reported
D. E. Shaw & Co., Inc.1.52%$17.1M0.01%Not reported
Woodline Partners LP1.20%$13.5M0.04%Not reported
Algert Global LLC1.17%$13.2M0.16%Not reported
Braidwell LP1.17%$13.2M0.49%Add 7.67%
Bank of America Corp1.04%$11.7M0.00%Not reported
Adage Capital Partners GP, L.L.C.1.02%$11.4M0.02%Add 205.51%
Defilade Capital Management, L.P.1.01%$11.3M1.52%Add 24.29%
Euclidean Capital LLC0.95%$10.7M2.44%Not reported
Royce & Associates LP0.95%$10.6M0.09%Not reported
Eventide Asset Management, LLC0.92%$10.3M0.14%Add 0.14%
Northern Trust Corp0.78%$8.73M0.00%Not reported
Qube Research & Technologies Ltd0.77%$8.6M0.01%Not reported
Sphera Funds Management Ltd.0.73%$8.15M1.06%Add 40.06%
Jones Hill Capital LP0.72%$8.09M1.72%New Not reported
Silverarc Capital Management, LLC0.71%$8M0.83%Reduce 32.83%
NEXTBio Capital Management LP0.68%$7.65M3.52%Add 34.85%
Millennium Management LLC0.67%$7.56M0.00%Not reported
Charles Schwab Investment Management Inc0.65%$7.34M0.00%Not reported
Vanguard Portfolio Management LLC0.61%$6.81M0.00%Not reported
Two Sigma Investments, LP0.58%$6.54M0.00%Not reported
ArrowMark Colorado Holdings LLC0.56%$6.31M0.26%Reduce 39.32%
Vanguard Fiduciary Trust Co0.55%$6.13M0.00%Not reported
Superstring Capital Management LP0.39%$4.4M2.78%Add 252.39%
Blue Owl Capital Holdings LP0.39%$4.33M0.65%Not reported
Victory Capital Management Inc0.38%$4.26M0.00%Not reported
Pfizer Inc0.36%$3.55M2.09%Reduce 92.20%
50 of 168 holders

Activity score

Premium
0
25
50
75
100
WEAK
STRONG
Unlock

AI Activity Analysis

Premium
Coming soonAI reads of insider, institutional and company activity will appear here for Premium accounts.

Historical Activity Patterns

Premium
Historical Activity PatternsHistorical periods where multiple activity categories converged, with subsequent market performance shown for context.Unlock

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.